Ferulamide

CAS No. 61012-31-5

Ferulamide ( 4-Hydroxy-3-methoxycinnamide )

Catalog No. M29143 CAS No. 61012-31-5

Ferulamide, a Ferulic acid derivative, shows potent inhibitory activity against arachidonic acid-induced platelet aggregation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 410 Get Quote
10MG 602 Get Quote
25MG 945 Get Quote
50MG 1278 Get Quote
100MG 1728 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ferulamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Ferulamide, a Ferulic acid derivative, shows potent inhibitory activity against arachidonic acid-induced platelet aggregation.
  • Description
    Ferulamide, a Ferulic acid derivative, shows potent inhibitory activity against arachidonic acid-induced platelet aggregation.(In Vitro):A series of Ferulamide derivatives were prepared and evaluated for their anti-platelet activities. Some of these compounds showed potent inhibitory activity against arachidonic acid-induced platelet aggregation. Their structure-activity relationships are also discussed.
  • Synonyms
    4-Hydroxy-3-methoxycinnamide
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    61012-31-5
  • Formula Weight
    193.2
  • Molecular Formula
    C10H11NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc(cc(/C=C/C(N)=O)cc1)c1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 12-Didecanoyl-sn-gly...

    12-Didecanoyl-sn-glycero-3-phosphocholi is a synthetic less hydrophobic phospholipid that has been found to be useful for enhancing the absorption of peptide drugs and hormones such as insulin.

  • Pamidronate disodium...

    Pamidronate disodium pentahydrate, a nitrogen-containing bisphosphonate, used to prevent osteoporosis.

  • JI-101

    JI-101 is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4).